首页 | 本学科首页   官方微博 | 高级检索  
     


EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization
Authors:Gillmore Roopinder  Stuart Sam  Kirkwood Amy  Hameeduddin Ayshea  Woodward Nick  Burroughs Andrew K  Meyer Tim
Affiliation:1 Department of Oncology, Royal Free Hospital, London, UK
2 Department of Radiology, Royal Free Hospital, London, UK
3 Cancer Research UK & UCL Cancer Trials Centre, London, UK
4 The Royal Free Sheila Sherlock Liver Centre, Royal Free Hospital, London, UK
5 UCL Cancer Institute, London, UK
Abstract:
Keywords:RECIST, response evaluation criteria in solid tumours   HCC, hepatocellular cancer   EASL, European Association for the Study of Liver   TAE, transarterial embolisation   TACE, transarterial chemoembolisation
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号